+33 (0)251 252 000 contact@inflectisbioscience.com

First-in-Class Therapies for Neurological Diseases

Our Approach

Develop multifunctional, brain penetrant, small molecules that act on different major pathophysiological mechanisms implicated in neurological diseases.

The Result

Potential new therapies that delay the progression of diseases such as Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth (CMT) and Multiple Sclerosis (MS).

Elif Ildem is training for the Paralympics in Japan in 2021. Since she started swimming as part of rehabilitation related to CMT, she has won several medals and competitions.